Singhal Anil K.
SEC insider (Form 3/4/5 filer). CIK 0001982984. Director at Werewolf Therapeutics, Inc. (HOWL). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2025. Located in WATERTOWN, MA.
Companies Singhal Anil K. has filed insider reports for
- Werewolf Therapeutics, Inc. (HOWL): Director
Singhal Anil K.
CIK: 0001982984
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HOWL
Werewolf Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 12, 2025HOWL
Werewolf Therapeutics, Inc.
AwardDirectStock Option (right to buy)
8.4K shares- - Jun 11, 2025HOWL
Werewolf Therapeutics, Inc.
AwardDirectStock Option (right to buy)
9K shares- - Feb 19, 2025HOWL
Werewolf Therapeutics, Inc.
AwardDirectStock Option (right to buy)
45K shares-
1-3 of 3 transactions